Globus Medical (GMED) EPS (Weighted Average and Diluted) (2011 - 2026)

Globus Medical has reported EPS (Weighted Average and Diluted) for 16 years, with the latest figure at $0.9 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 66.67% year-over-year to $0.9; the trailing twelve-month figure through Mar 2026 stood at $4.29 (up 220.15% YoY), and the FY2025 full-year result was $3.92, up 422.67% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.9, down from $1.02 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $1.49 in Q2 2025, with the low at -$0.05 in Q1 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.51 across 5 years, with a median of $0.48 in 2023.
• The largest YoY upside for EPS (Weighted Average and Diluted) was 3700.0% in 2024 against a maximum downside of 110.42% in 2024.
• Globus Medical's EPS (Weighted Average and Diluted) stood at $0.49 in 2022, then slumped by 81.63% to $0.09 in 2023, then surged by 111.11% to $0.19 in 2024, then soared by 436.84% to $1.02 in 2025, then dropped by 11.76% to $0.9 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.9 (Q1 2026), $1.02 (Q4 2025), and $0.88 (Q3 2025), per Business Quant data.